2016
DOI: 10.1016/j.ahj.2016.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0
4

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 67 publications
(30 citation statements)
references
References 39 publications
1
25
0
4
Order By: Relevance
“…This specificity was significantly superior to a single measurement strategy for HS-assays, cTnI-Pathfast, cTnI-Ultra and cTnI-Vista. Our results are comparable to those in the literature when considering HS assays [6] , [17] , [18] , [22] , [30] , but also cTnI Access, cTnI-Vista, cTnI-Vitros, cTnI-AQT [5] , [7] , [14] , [30] , and cTnT-AQT [19] , [30] , although comparison is limited because of the sample size of the population and study protocols (some data in the literature is reported for H0-H2). Moreover, the percentage of rule-out patients with these H0-H3 strategies is elevated for all assays.…”
Section: Discussionsupporting
confidence: 85%
See 2 more Smart Citations
“…This specificity was significantly superior to a single measurement strategy for HS-assays, cTnI-Pathfast, cTnI-Ultra and cTnI-Vista. Our results are comparable to those in the literature when considering HS assays [6] , [17] , [18] , [22] , [30] , but also cTnI Access, cTnI-Vista, cTnI-Vitros, cTnI-AQT [5] , [7] , [14] , [30] , and cTnT-AQT [19] , [30] , although comparison is limited because of the sample size of the population and study protocols (some data in the literature is reported for H0-H2). Moreover, the percentage of rule-out patients with these H0-H3 strategies is elevated for all assays.…”
Section: Discussionsupporting
confidence: 85%
“…The literature is scarce concerning studies measuring several cTn assays in a single population. Wildi et al recently reported data on 4 HS assays and 3 sensitive assays [6] , but some assays were in a pre-commercial version. Here, we report data on fully commercial and routinely used HS, sensitive and POC assays, which we compare to the literature.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Current evidence suggests that usual care with conventional cTn assays 5 or a single sensitive troponin assay may be as effective as hs-cTnT when patients are appropriately stratified as being at low risk for acute myocardial infarction. 6 However, owing to a wide practice variation for an "acceptable miss rate" 7 and diverse causes for presenting symptoms, 8 admission for serial cTn and provocative testing is common. 1 Implementation of hs-cTnT may enable patients to be safely discharged from the ED earlier than in current practice; however, the reduced specificity may negate the benefits of ED throughput by increasing hospital admission, health care spending, and invasive interventions.…”
Section: Commentarymentioning
confidence: 99%
“…As a result of ever increasing time constraints, patient-centred communication is severely under pressure. Scientific advances have accelerated diagnostic pathways and rendered possible 'fast-track' emergency care, such as the rapid exclusion of myocardial infarction [10]. Therefore, an expeditious diagnostic process needs to be matched by timely and efficient discharge communication.…”
Section: Introductionmentioning
confidence: 99%